The FDA has said it cannot approve AbbVie’s Parkinson’s disease drug ABBV-951, designed to provide continuous control of symptoms, saying it needs more information about t
Bayer subsidiary BlueRock Therapeutics is evaluating digital health technologies that it hopes could support the development of its stem cell-based therapy for Parkinson’s
Five wearable devices that monitor patients with Parkinson's disease as they go about their lives have been given a provisional recommendation from NICE, making them available via the NHS w
Software that can be used to monitor patients with neurodegenerative disorder amyotrophic lateral sclerosis (ALS) using their voice patterns has been granted breakthrough